Satter Muneer A 13D and 13G filings for Whitehawk Therapeutics Inc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 4:59 pm Sale | 2024-12-31 | 13G | Whitehawk Therapeutics Inc WHWK | Satter Muneer A | 659 0.000% | -1,630,171 (-99.96%) | Filing |
| 2023-02-10 1:04 pm Purchase | 2022-12-31 | 13G | Whitehawk Therapeutics Inc WHWK | Satter Muneer A | 1,630,830 6.700% | 336,045 (+25.95%) | Filing |
| 2022-10-04 4:01 pm Purchase | 2022-09-26 | 13G | Whitehawk Therapeutics Inc WHWK | Satter Muneer A | 1,294,785 5.300% | 1,294,785 (New Position) | Filing |